Docetaxel epirubicin adjuvant trial (DEVA)

• Research type

  Research Study

• Full title

  A Multicentre Randomised Trial of Sequential Epirubucin and Docetaxel versus Epirubicin in Node Positive Postmenopausal Breast Cancer Patients

• Contact name

  Charles Coombes

• Sponsor organisation

  Imperial College of Science, Technology & Medicine

• Eudract number

  2004-000584-96

• ISRCTN Number

  eudract

• Research summary

  Research Summary not yet available

• REC name

  London - Central Research Ethics Committee

• REC reference

  MREC/99/2/01

• Date of REC Opinion

  21 Jan 2010

• REC opinion

  Favourable Opinion